Bayer CEO: Patient distrust of tech holds back gene-editing advances

Bayer CEO: Patient distrust of tech holds back gene-editing advances
Walter Baumann said at an event in Davos there was ‘less and less trust’ for tech advances in contentious areas.
News story posted on 2020-01-22T10:49:00.0000000Z